Hepatotoxicity and Accelerated Fibrosis Following 3,4-Methylenedioxymetamphetamine (“Ecstasy”) Usage
- 1 April 1995
- journal article
- case report
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 20 (3) , 244-247
- https://doi.org/10.1097/00004836-199504000-00017
Abstract
3,4-Methylenedioxymetamphetamine ("ecstasy") has previously been reported to cause an acute hepatitis that may progress to liver failure. We present the first recorded case of ecstasy-induced accelerated hepatic fibrosis.Keywords
This publication has 0 references indexed in Scilit: